Evidence map›Paper›PMID 37375179›Full record

ArticleMolecules (Basel, Switzerland)2023

Novel Red-Emitting Eu

Fan Chen, Muhammad Nadeem Akram, Xuyuan Chen

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Influence of MnMicromachines · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fan ChenDepartment of Microsystems, Faculty of Technology, Natural Sciences and Maritime Sciences, Campus Vestfold, University of South-Eastern Norway, 3184 Borre, Norway.
Muhammad Nadeem AkramDepartment of Microsystems, Faculty of Technology, Natural Sciences and Maritime Sciences, Campus Vestfold, University of South-Eastern Norway, 3184 Borre, Norway.
Xuyuan ChenDepartment of Microsystems, Faculty of Technology, Natural Sciences and Maritime Sciences, Campus Vestfold, University of South-Eastern Norway, 3184 Borre, Norway.ORCID 0000-0003-0526-0648

Funding

Research Council of Norway FORNY RedOX project
6 · The paper itself

Abstract

In this study, a series of trivalent europium-doped tungstate and molybdate samples were synthesized using an improved sol-gel and high-temperature solid-state reaction method. The samples had different W/Mo ratios and were calcined at various temperatures ranging from 800 to 1000 °C. The effects of these variables on the crystal structure and photoluminescence characteristics of the samples were investigated. It was found that a doping concentration of 50% for europium yielded the best quantum efficiency based on previous research. The crystal structures were found to be dependent on the W/Mo ratio and calcination temperature. Samples with x ≤ 0.5 had a monoclinic lattice structure that did not change with calcination temperature. Samples with x > 0.75 had a tetragonal structure that remained unchanged with calcination temperature. However, samples with x = 0.75 had their crystal structure solely dependent on the calcination temperature. At 800-900 °C, the crystal structure was tetragonal, while at 1000 °C, it was monoclinic. Photoluminescence behavior was found to correlate with crystal structure and grain size. The tetragonal structure had significantly higher internal quantum efficiency than the monoclinic structure, and smaller grain size had higher internal quantum efficiency than larger grain size. External quantum efficiency initially increased with increasing grain size and then decreased. The highest external quantum efficiency was observed at a calcination temperature of 900 °C. These findings provide insight into the factors affecting the crystal structure and photoluminescence behavior in trivalent europium-doped tungstate and molybdate systems.

Indexed as

Eu3+ dopedlaser lightingquantum efficiencyred phosphorthermal quenching

Identifiers

PMID37375179
PMCPMC10303167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.